Skip to content
10-Q

Quarterly Report

CRISPR Therapeutics AG CRSP

0000950170-25-102052

← back to feed
Filed
Aug 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 90.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 87.07M sh
Shares Diluted Q2 2025 · Jun 30, 2025 86.51M sh
Shares Diluted Q2 2025 · Jun 30, 2024 84.92M sh
Shares Diluted Q2 2025 · Jun 30, 2024 83.36M sh
Capex Q2 2025 · Jun 30, 2025 $323K
Capex Q2 2025 · Jun 30, 2024 $1.43M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$167.83M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $14.17M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $193.62M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $298.26M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $484.47M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.71B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.83B
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.93B
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.98B
Stockholders Equity Q2 2025 · Mar 31, 2024 $2.08B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.88B
Current Liabilities Q2 2025 · Jun 30, 2025 $104.36M
Current Liabilities Q2 2025 · Dec 31, 2024 $87.78M
Total Liabilities Q2 2025 · Jun 30, 2025 $318.59M
Total Liabilities Q2 2025 · Dec 31, 2024 $309.95M
Current Assets Q2 2025 · Jun 30, 2025 $1.73B
Current Assets Q2 2025 · Dec 31, 2024 $1.94B
Total Assets Q2 2025 · Jun 30, 2025 $2.03B
Total Assets Q2 2025 · Dec 31, 2024 $2.24B
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.40
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.98
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.49
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.92
Eps Basic Q2 2025 · Jun 30, 2025 −$2.40
Eps Basic Q2 2025 · Jun 30, 2025 −$3.98
Eps Basic Q2 2025 · Jun 30, 2024 −$1.49
Eps Basic Q2 2025 · Jun 30, 2024 −$2.92
Sga Expense Q2 2025 · Jun 30, 2025 $18.92M
Sga Expense Q2 2025 · Jun 30, 2025 $38.21M
Sga Expense Q2 2025 · Jun 30, 2024 $19.48M
Sga Expense Q2 2025 · Jun 30, 2024 $37.43M
Rd Expense Q2 2025 · Jun 30, 2025 $69.89M
Rd Expense Q2 2025 · Jun 30, 2025 $142.38M
Rd Expense Q2 2025 · Jun 30, 2024 $80.17M
Rd Expense Q2 2025 · Jun 30, 2024 $156.34M
Net Income Q2 2025 · Jun 30, 2025 −$208.55M
Net Income Q2 2025 · Jun 30, 2025 −$344.55M
Net Income Q2 2025 · Mar 31, 2025 −$136M
Net Income Q2 2025 · Jun 30, 2024 −$126.41M
Net Income Q2 2025 · Jun 30, 2024 −$243M
Net Income Q2 2025 · Mar 31, 2024 −$116.59M
Operating Income Q2 2025 · Jun 30, 2025 −$229.32M
Operating Income Q2 2025 · Jun 30, 2025 −$377.75M
Operating Income Q2 2025 · Jun 30, 2024 −$151.26M
Operating Income Q2 2025 · Jun 30, 2024 −$291.85M
Revenue Q2 2025 · Jun 30, 2025 $892K
Revenue Q2 2025 · Jun 30, 2025 $1.76M
Revenue Q2 2025 · Jun 30, 2024 $517K
Revenue Q2 2025 · Jun 30, 2024 $1.02M